These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 19349293

  • 1. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, Heering P, Ivens K.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [Abstract] [Full Text] [Related]

  • 2. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.
    Pereira AC, Miyakawa AA, Lopes NH, Soares PR, de Oliveira SA, Cesar LA, Ramires JF, Hueb W, Krieger JE.
    Thromb Res; 2007 Sep; 121(1):25-32. PubMed ID: 17604826
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN, Carey JA, Barnard J, Fildes JE, Pravica V, Yonan N, Hutchinson IV.
    Heart Surg Forum; 2005 Sep; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [Abstract] [Full Text] [Related]

  • 4. Influence of cytokine gene polymorphisms on IgA nephropathy.
    Bantis C, Heering P, Aker S, Kuhr N, Grabensee B, Ivens K.
    Ren Fail; 2008 Sep; 30(2):135-40. PubMed ID: 18300111
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W.
    BMC Cardiovasc Disord; 2005 May 20; 5(1):10. PubMed ID: 15943888
    [Abstract] [Full Text] [Related]

  • 6. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E, Undas A, Sniezek-Maciejewska M, Kapelak B, Plicner D, Stepien E, Sadowski J.
    Ann Clin Biochem; 2010 Jul 20; 47(Pt 4):343-9. PubMed ID: 20592333
    [Abstract] [Full Text] [Related]

  • 7. Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Wacinski P, Zukowski P, Dragan M, Bednarek-Skublewska A.
    Hum Immunol; 2010 Sep 20; 71(9):878-82. PubMed ID: 20538029
    [Abstract] [Full Text] [Related]

  • 8. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R, RISCAVID Study Group.
    Nephrol Dial Transplant; 2008 Jul 20; 23(7):2337-43. PubMed ID: 18305316
    [Abstract] [Full Text] [Related]

  • 9. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.
    Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K.
    Clin Transplant; 2007 Jul 20; 21(5):615-21. PubMed ID: 17845635
    [Abstract] [Full Text] [Related]

  • 10. The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients.
    Antonicelli R, Olivieri F, Bonafè M, Cavallone L, Spazzafumo L, Marchegiani F, Cardelli M, Recanatini A, Testarmata P, Boemi M, Parati G, Franceschi C.
    Int J Cardiol; 2005 Sep 01; 103(3):266-71. PubMed ID: 16098388
    [Abstract] [Full Text] [Related]

  • 11. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A.
    Coron Artery Dis; 2007 Aug 01; 18(5):333-7. PubMed ID: 17627181
    [Abstract] [Full Text] [Related]

  • 12. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S, Lindholm B, Axelsson J, Qureshi RA, Barany P, Heimbürger O, Gustafsson JA, Stenvinkel P, Nordfors L.
    Nephrol Dial Transplant; 2007 Sep 01; 22(9):2571-7. PubMed ID: 17452407
    [Abstract] [Full Text] [Related]

  • 13. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
    Altun B, Yilmaz R, Kahraman S, Gençtoy G, Arici M, Onalan O, Oto A, Hayran M, Bakkaloğlu M, Yasavul U, Turgan C.
    Transpl Int; 2005 Jun 01; 18(6):681-9. PubMed ID: 15910294
    [Abstract] [Full Text] [Related]

  • 14. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Jun 01; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 15. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH, de Paula FJ, César LA, Martinez Filho EE, Ianhez LE, Krieger EM, Ramires JA, de Lima JJ.
    Coron Artery Dis; 2007 Nov 01; 18(7):553-8. PubMed ID: 17925609
    [Abstract] [Full Text] [Related]

  • 16. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G, Bosson JL, Golshayan D, Barro C, Alloatti S, Turc-Baron C, Quarello F, Jeantet A, Von Albertini B, Forêt M, Lauren G, Cordonnier D, Piccoli G, Wauters JP, Diamant Alpin Collaborative Dialysis Study Group.
    J Nephrol; 2004 Nov 01; 17(1):66-75. PubMed ID: 15151261
    [Abstract] [Full Text] [Related]

  • 17. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
    Kolek MJ, Carlquist JF, Muhlestein JB, Whiting BM, Horne BD, Bair TL, Anderson JL.
    Am Heart J; 2004 Dec 01; 148(6):1034-40. PubMed ID: 15632890
    [Abstract] [Full Text] [Related]

  • 18. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
    Joki N, Tanaka Y, Ishikawa H, Takahashi Y, Iwakura Y, Masuda H, Inishi Y, Hase H.
    Am J Nephrol; 2009 Dec 01; 29(5):420-5. PubMed ID: 18997458
    [Abstract] [Full Text] [Related]

  • 19. Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.
    Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, Bickel C, Nicaud V, Schnabel R, Kee F, Morrison C, Evans A, Lackner KJ, Cambien F, Münzel T, Tiret L, AtheroGene Investigators.
    Circ Res; 2006 Jul 07; 99(1):102-8. PubMed ID: 16778130
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
    Trivedi H, Xiang Q, Klein JP.
    Nephrol Dial Transplant; 2009 Jan 07; 24(1):258-66. PubMed ID: 18682489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.